메뉴 건너뛰기




Volumn 51, Issue 5, 2007, Pages 1804-1812

Modeling the combination of amphotericin B, micafungin, and nikkomycin Z against Aspergillus fumigatus in vitro using a novel response surface paradigm

Author keywords

[No Author keywords available]

Indexed keywords

2,3 BIS[2 METHOXY 4 NITRO 5 [(SULFENYLAMINO)CARBONYL] 2H TETRAZOLIUM HYDROXIDE]; AMPHOTERICIN B DEOXYCHOLATE; MICAFUNGIN; NIKKOMYCIN Z; TETRAZOLIUM; UNCLASSIFIED DRUG;

EID: 34248357105     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01007-06     Document Type: Article
Times cited : (19)

References (33)
  • 1
    • 0017843255 scopus 로고
    • A method for testing for synergy for any number of agents
    • Berenbaum, M. C. 1978. A method for testing for synergy for any number of agents. J. Infect. Dis. 137:122-130.
    • (1978) J. Infect. Dis , vol.137 , pp. 122-130
    • Berenbaum, M.C.1
  • 2
    • 34248398162 scopus 로고    scopus 로고
    • Modeling of the three fungal agents combination (amphotericin B, micafungin, and nikkomycin Z) against Aspergillus fumigatus in vitro using a novel response surface paradigm
    • Brun, Y., et al. 2006. Modeling of the three fungal agents combination (amphotericin B, micafungin, and nikkomycin Z) against Aspergillus fumigatus in vitro using a novel response surface paradigm. Clin. Pharmacol. Ther. 79:P28.
    • (2006) Clin. Pharmacol. Ther , vol.79
    • Brun, Y.1
  • 3
    • 0035185523 scopus 로고    scopus 로고
    • Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus
    • Chiou, C. C., N. Mavrogiorgos, E. Tillem, R. Hector, and T. J. Walsh. 2001. Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus. Antimicrob. Agents Chemother. 45:3310-3321.
    • (2001) Antimicrob. Agents Chemother , vol.45 , pp. 3310-3321
    • Chiou, C.C.1    Mavrogiorgos, N.2    Tillem, E.3    Hector, R.4    Walsh, T.J.5
  • 8
    • 9444248159 scopus 로고    scopus 로고
    • In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus
    • Ganesan, L. T., E. K. Manavathu, J. L. Cutright, G. J. Alangaden, and P. H. Chandrasekar. 2004. In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus. Clin. Microbiol. Infect. 10:961-966.
    • (2004) Clin. Microbiol. Infect , vol.10 , pp. 961-966
    • Ganesan, L.T.1    Manavathu, E.K.2    Cutright, J.L.3    Alangaden, G.J.4    Chandrasekar, P.H.5
  • 9
    • 0025113618 scopus 로고
    • Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-β-D- arabinofuranosylcytosine
    • Greco, W. R., H. S. Park, and Y. M. Rustum. 1990. Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-β-D- arabinofuranosylcytosine. Cancer Res. 50:5318-5327.
    • (1990) Cancer Res , vol.50 , pp. 5318-5327
    • Greco, W.R.1    Park, H.S.2    Rustum, Y.M.3
  • 10
    • 23244447174 scopus 로고    scopus 로고
    • Surface response modeling to examine the combination of amphotericin B deoxycholate and 5-fluorocytosine for treatment of invasive candidiasis
    • Hope, W. W., P. A. Warn, A. Sharp, P. Reed, B. Keevil, A. Louie, D. W. Denning, and G. L. Drusano. 2005. Surface response modeling to examine the combination of amphotericin B deoxycholate and 5-fluorocytosine for treatment of invasive candidiasis. J. Infect. Dis. 192:673-680.
    • (2005) J. Infect. Dis , vol.192 , pp. 673-680
    • Hope, W.W.1    Warn, P.A.2    Sharp, A.3    Reed, P.4    Keevil, B.5    Louie, A.6    Denning, D.W.7    Drusano, G.L.8
  • 12
    • 3242703074 scopus 로고    scopus 로고
    • Toward more effective antifungal therapy: The prospects of combination therapy
    • Kontoyiannis, D. P., and R. E. Lewis. 2004. Toward more effective antifungal therapy: the prospects of combination therapy. Br. J. Haematol. 126:165-175.
    • (2004) Br. J. Haematol , vol.126 , pp. 165-175
    • Kontoyiannis, D.P.1    Lewis, R.E.2
  • 13
    • 0000178985 scopus 로고
    • Effect of combinations: Mathematical basis of problem
    • Loewe, S., and H. Muischnek. 1926. Effect of combinations: mathematical basis of problem. Arch. Exp. Pathol. Pharmacol. 11:313-326.
    • (1926) Arch. Exp. Pathol. Pharmacol , vol.11 , pp. 313-326
    • Loewe, S.1    Muischnek, H.2
  • 14
    • 33845574728 scopus 로고    scopus 로고
    • Maertens, J., A. Glasmacher, R. Herbrecht, A. Thiebaut, C. Cordonnier, B. H. Segal, J. Killar, A. Taylor, N. Kartsonis, T. F. Patterson, M. Aoun, D. Caillot, C. Sable, and the Caspofungin Combination Therapy Study Group. 2006. Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis. Cancer 107:2888-2897.
    • Maertens, J., A. Glasmacher, R. Herbrecht, A. Thiebaut, C. Cordonnier, B. H. Segal, J. Killar, A. Taylor, N. Kartsonis, T. F. Patterson, M. Aoun, D. Caillot, C. Sable, and the Caspofungin Combination Therapy Study Group. 2006. Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis. Cancer 107:2888-2897.
  • 18
    • 0019852616 scopus 로고
    • Metabolic products of microorganisms: Inhibition of chitosomal chitin synthetase and growth of Mucor rouxii by nikkomycin Z, nikkomycin X and polyoxin A: a comparison
    • Muller, H., R. Furter, H. Zahner, and D. M. Rast. 1981. Metabolic products of microorganisms: inhibition of chitosomal chitin synthetase and growth of Mucor rouxii by nikkomycin Z, nikkomycin X and polyoxin A: a comparison. Arch. Microbiol. 130:195-197.
    • (1981) Arch. Microbiol , vol.130 , pp. 195-197
    • Muller, H.1    Furter, R.2    Zahner, H.3    Rast, D.M.4
  • 19
    • 0028973391 scopus 로고
    • Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis
    • Nagai, H., J. Guo, H. Choi, and V. Kurup. 1995. Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis. J. Infect. Dis. 172:1554-1560.
    • (1995) J. Infect. Dis , vol.172 , pp. 1554-1560
    • Nagai, H.1    Guo, J.2    Choi, H.3    Kurup, V.4
  • 20
    • 34248393616 scopus 로고    scopus 로고
    • NCCLS. 2002. Performance standards for antimicrobial susceptibility testing; 12th Informational Supplement. NCCLS M100-S12. NCCLS, Wayne, PA.
    • NCCLS. 2002. Performance standards for antimicrobial susceptibility testing; 12th Informational Supplement. NCCLS M100-S12. NCCLS, Wayne, PA.
  • 21
    • 28644434509 scopus 로고    scopus 로고
    • Nierman, W, A. Pain, M. J. Anderson, J. Wortman, H. S. Kim, J. Arroya, B. Berriman, K. Abe, D. B. Archer, C. Bermejo, J. Bennett, P. Bowyer, D. Chen, M. Collins, R. Coulsen, R. Davies, P. S. Dyer, M. Farman, N. Federova, N. Federova, T. V. Feldblyum, R. Fischer, N. Fosker, A. Fraser, J. L. García, M. J. García, A. Goble, G. H. Goldman, K. Gomi, S. Griffith-Jones, R. Gwilliam, B. Haas, H. Haas, D. Harris, H. Horiuchi, J. Huang, S. Humphrey, J. Jiménez, N. Keller, H. Khouri, K. Kitamoto, T. Kobayashi, S. Konzack, R. Kulkarni, T. Kumagai, A. Lafton, J. P. Latgé, A. Lord, W. Li, C. Lu, W. H. Majoros, G. S. May, B. L. Miller, Y. Mohamoud, M. Molina, M. Monod, I. Mouyna, S. Mulligan, L. Murphy, S. O'Neil, I. Paulsen, M. A. Peñalva, M. Pertea, C. Price, B. L. Pritchard, M. A. Quail, E. Rabbinowitsch, N. Rawlins, M.-A. Rajandream, V. Reichard, H. Renauld, G. D. Robson, S. Rodriguez de Córdoba, J. M. Rodríguez-Peña, C. M. Ronning, S. Rut
    • Nierman, W., A. Pain, M. J. Anderson, J. Wortman, H. S. Kim, J. Arroya, B. Berriman, K. Abe, D. B. Archer, C. Bermejo, J. Bennett, P. Bowyer, D. Chen, M. Collins, R. Coulsen, R. Davies, P. S. Dyer, M. Farman, N. Federova, N. Federova, T. V. Feldblyum, R. Fischer, N. Fosker, A. Fraser, J. L. García, M. J. García, A. Goble, G. H. Goldman, K. Gomi, S. Griffith-Jones, R. Gwilliam, B. Haas, H. Haas, D. Harris, H. Horiuchi, J. Huang, S. Humphrey, J. Jiménez, N. Keller, H. Khouri, K. Kitamoto, T. Kobayashi, S. Konzack, R. Kulkarni, T. Kumagai, A. Lafton, J. P. Latgé, A. Lord, W. Li, C. Lu, W. H. Majoros, G. S. May, B. L. Miller, Y. Mohamoud, M. Molina, M. Monod, I. Mouyna, S. Mulligan, L. Murphy, S. O'Neil, I. Paulsen, M. A. Peñalva, M. Pertea, C. Price, B. L. Pritchard, M. A. Quail, E. Rabbinowitsch, N. Rawlins, M.-A. Rajandream, V. Reichard, H. Renauld, G. D. Robson, S. Rodriguez de Córdoba, J. M. Rodríguez-Peña, C. M. Ronning, S. Rutter, S. L. Salzberg, S. Sanchez, J. C. Sánchez-Ferrero, D. Saunders, K. Seeger, R. Squares, S. Squares, T. Takeuchi, F. Tekaia, G. Turner, C. R. Vazquez de Aldana, J. Weidman, O. White, J. Woodward, J.-H. Yu, C. Fraser, J. E. Galagan, K. Asai, M. Machida, N. Hall, B. Barrell, and D. W. Denning. 2005. Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature 438:1151-1156.
  • 24
    • 33645302916 scopus 로고    scopus 로고
    • Current approaches to diagnosis and treatment of invasive aspergillosis
    • Segal, B. H., and T. J. Walsh. 2006. Current approaches to diagnosis and treatment of invasive aspergillosis. Am. J. Respir. Crit. Care Med. 173:707-717
    • (2006) Am. J. Respir. Crit. Care Med , vol.173 , pp. 707-717
    • Segal, B.H.1    Walsh, T.J.2
  • 26
    • 4344606553 scopus 로고    scopus 로고
    • Steinbach, W. J., J. R. Perfect, W. A. Schell, T. J. Walsh, and D. K. Benjamin, Jr. 2004. In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection. Antimicrob. Agents Chemother. 48: 3217-3225.
    • Steinbach, W. J., J. R. Perfect, W. A. Schell, T. J. Walsh, and D. K. Benjamin, Jr. 2004. In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection. Antimicrob. Agents Chemother. 48: 3217-3225.
  • 27
    • 33749528153 scopus 로고    scopus 로고
    • Combination antifungal therapy for invasive aspergillosis. Is it indicated?
    • Steinbach, W. J. 2006. Combination antifungal therapy for invasive aspergillosis. Is it indicated? Med. Mycol. 44(Suppl. 1):373-382.
    • (2006) Med. Mycol , vol.44 , Issue.SUPPL. 1 , pp. 373-382
    • Steinbach, W.J.1
  • 28
    • 0033844896 scopus 로고    scopus 로고
    • Drug interaction studies of a glucan synthase inhibitor (LY 303366) and a chitin synthase inhibitor (nikkomycin Z) for inhibition and killing of fungal pathogens
    • Stevens, D. A. 2000. Drug interaction studies of a glucan synthase inhibitor (LY 303366) and a chitin synthase inhibitor (nikkomycin Z) for inhibition and killing of fungal pathogens. Antimicrob. Agents Chemother. 44:2547-2548.
    • (2000) Antimicrob. Agents Chemother , vol.44 , pp. 2547-2548
    • Stevens, D.A.1
  • 30
    • 2542445436 scopus 로고    scopus 로고
    • In vitro interactions between amphotericin B, itraconazole, and flucytosine against 21 clinical Aspergillus isolates determined by two drug interaction models
    • Te Dorsthorst, D. T. A., P. E. Verweij, J. F. G. M. Meis, N. C. Punt, and J. W. Mouton. 2004. In vitro interactions between amphotericin B, itraconazole, and flucytosine against 21 clinical Aspergillus isolates determined by two drug interaction models. Antimicrob. Agents Chemother. 48:2007-2013.
    • (2004) Antimicrob. Agents Chemother , vol.48 , pp. 2007-2013
    • Te Dorsthorst, D.T.A.1    Verweij, P.E.2    Meis, J.F.G.M.3    Punt, N.C.4    Mouton, J.W.5
  • 31
    • 0042816537 scopus 로고    scopus 로고
    • Walsh, T. J., V. Petraitis, R. Petraitiene, A. Field-Ridley, D. Sutton, M. Ghannoum, T. Sein, R. Schaufele, J. Peter, J. Bacher, H. Casler, D. Armstrong, A. Espinel-Ingroff, M. G. Rinaldi, and C. A. Lyman. 2003. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. J. Infect. Dis. 188:305-319.
    • Walsh, T. J., V. Petraitis, R. Petraitiene, A. Field-Ridley, D. Sutton, M. Ghannoum, T. Sein, R. Schaufele, J. Peter, J. Bacher, H. Casler, D. Armstrong, A. Espinel-Ingroff, M. G. Rinaldi, and C. A. Lyman. 2003. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. J. Infect. Dis. 188:305-319.
  • 32
    • 0037394460 scopus 로고    scopus 로고
    • Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B
    • Warn, P. A., G. Morrissey, J. Morrissey, and D. W. Denning. 2003. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B. J. Antimicrob. Chemother. 51:913-919.
    • (2003) J. Antimicrob. Chemother , vol.51 , pp. 913-919
    • Warn, P.A.1    Morrissey, G.2    Morrissey, J.3    Denning, D.W.4
  • 33
    • 0142074686 scopus 로고    scopus 로고
    • A new nonlinear mixture response surface paradigm for the study of synergism: A three drug example
    • White, D. B., H. K. Slocum, Y. F. Brun, C. Wrzosek, and W. R. Greco. 2003. A new nonlinear mixture response surface paradigm for the study of synergism: a three drug example. Curr. Drug Metab. 2:399-409.
    • (2003) Curr. Drug Metab , vol.2 , pp. 399-409
    • White, D.B.1    Slocum, H.K.2    Brun, Y.F.3    Wrzosek, C.4    Greco, W.R.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.